Regulus Therapeutics Inc (NAS:RGLS)
$ 1.6 -0.01 (-0.62%) Market Cap: 104.80 Mil Enterprise Value: 18.95 Mil PE Ratio: 0 PB Ratio: 1.20 GF Score: 41/100